title: Barrett's esophagus.
abstract: Patients with Barrett's esophagus have 30-40 times higher risk of developing adenocarcinoma of distal esophagus. Treatment of Barrett's esophagus without dysplasia is identical with treatment of gastroesophageal reflux disease. (Tab. 1, Ref. 5.).
authors.affiliation: National Cancer Institute, Bratislava, Slovakia. kollar@nou.sk
authors.forename: T
authors.initials: T
authors.lastname: Kollar
authors.forename: J
authors.initials: J
authors.lastname: Majek
authors.forename: P
authors.initials: P
authors.lastname: Slezak
authors.forename: P
authors.initials: P
authors.lastname: Makovnik
authors.forename: P
authors.initials: P
authors.lastname: Mlkvy
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology; D001471:Barrett Esophagus / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D004938:Esophageal Neoplasms / Q000209:etiology; D006801:Humans; D012307:Risk Factors